Baytril Purple Tablets 68mg - 50ct

Indicated for the treatment of skin and wound infections, respiratory infections, tonsillitis and urinary tract infections in dogs. The use of enrofloxacin is contraindicated in small and medium breeds of dogs in the rapid growth phase (between 2 and 8 months of age). The safe use of enrofloxacin has not been established in large and giant breeds of dogs during the rapid growth phase.

Dosage & Administration:
Dogs:
Administer orally at a rate to provide 5 to 20 mg/kg (2.27 to 9.07 mg/lbs) of body weight. Selection of a dose within the range should be based on clinical experience, the severity of disease and susceptibility of the pathogen. Animals which receive doses in the upper-end of this dose range should be carefully monitored for clinical signs that may include inappetance, depression and vomitation.

Cats:
Administer orally at 5 mg/kg (2.27 mg/lbs) of body weight. The Selection of a dose within the range should be based on clinical experience, the severity of disease and susceptibility of the pathogen. The dose should be continued for at least 2 to 3 days beyond cessation of clinical signs, to a maximum of 30 days. These tablets are not flavored and are purple in color.

View Patient Information Sheet